These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1222395)

  • 21. [Fiberoptic bronchoscopy-gold vapor laser treatment of bronchogenic carcinoma].
    Deng WW
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):25-6, 63. PubMed ID: 2848635
    [No Abstract]   [Full Text] [Related]  

  • 22. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical evaluation of an innoxious antineoplastic agent: preliminary study of 106 patients treated with or without RSV after pulmonary resection for bronchogenic carcinoma.
    Hansen JL
    Cancer Chemother Rep 3; 1973 Mar; 4(2):261-4. PubMed ID: 4729327
    [No Abstract]   [Full Text] [Related]  

  • 25. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T; Marino C; Nozzoli F; Lopes-Pegna A; Righi R; Santomaggio C; Lamanna S; Periti P
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of chemotherapy in lung cancer (controlled trials).
    Shnider BI
    Med Ann Dist Columbia; 1971 Aug; 40(8):489-95. PubMed ID: 5001653
    [No Abstract]   [Full Text] [Related]  

  • 27. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of bronchogenic carcinoma presenting with acute abdomen.
    Habeşoğlu MA; Oğuzülgen KI; Oztürk C; Akyürek N; Memiş L
    Tuberk Toraks; 2005; 53(3):280-3. PubMed ID: 16258889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy of inoperable bronchogenic carcinoma.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1985; 27(3):175-89. PubMed ID: 3017850
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of response to ifosfamide in squamous cell bronchogenic carcinoma.
    Banks J; Anderson EG; Smith AP
    Cancer Chemother Pharmacol; 1989; 23(2):128. PubMed ID: 2910511
    [No Abstract]   [Full Text] [Related]  

  • 31. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 32. Photodynamic laser therapy for the treatment of early-stage bronchogenic carcinoma.
    Patelli M; Lazzari Agli L; Poletti V; Falcone F
    Monaldi Arch Chest Dis; 1999 Aug; 54(4):315-8. PubMed ID: 10546472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
    Presant CA; Hillinger S; Klahr C
    Cancer; 1980 Jan; 45(1):6-10. PubMed ID: 6243243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunorestoration in epidermoid cancer of the bronchi. Therapeutic results (proceedings)].
    Pouillart P; Palangie T; Jouve M; Huguenin P; Gautier H; Morin P; Baron A
    J Radiol Electrol Med Nucl; 1978 Nov; 59(11):654-7. PubMed ID: 748546
    [No Abstract]   [Full Text] [Related]  

  • 35. [Photodynamic therapy of bronchogenic cancer].
    Guillemin F; Feintrenie X; Lignon D
    Rev Pneumol Clin; 1992; 48(3):111-4. PubMed ID: 1439461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced epidermoid lung cancer: prolonged survival after chemotherapy.
    Richards F; Cooper MR; White DR; Muss HB; Jackson DV; Stuart JJ; Spurr CL
    Cancer; 1980 Jul; 46(1):34-7. PubMed ID: 7388765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of lung cancer by a cooperative group: EORTC Lung Cancer Working Party (Belgium)].
    Klastersky J; Sculier JP
    Rev Med Brux; 1983 Sep; 4(7):485-9. PubMed ID: 6316462
    [No Abstract]   [Full Text] [Related]  

  • 38. [The role of selective bronchial arterial infusion in the comprehensive treatment of advanced bronchial carcinoma].
    Sun SL
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Oct; 12(5):286-7, 319. PubMed ID: 2561087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of emetine (NSC-33669) in the treatment of solid tumors.
    Siddiqui S; Firat D; Olshin S
    Cancer Chemother Rep; 1973; 57(4):423-8. PubMed ID: 4586950
    [No Abstract]   [Full Text] [Related]  

  • 40. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
    Rosenthal CJ; Ritter S; Platica O
    Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.